Breast Cancer Pharmacology (medical)

Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer

Said Furkan Yildirim, Pervin Demir, Hakan Kosku, Bulent Yalcin, Ahmet Cevdet Ceylan
Springer Nature · 2026-09-25 · DOI 10.1007/s12282-026-01913-9

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →